glp-1 substance abuse Not just obesity: receptor agonists advance on addiction GLP-1 Agonist Addiction Treatment |

These medications were initially meant for the management of type 2 diabetes but have become popular for weight loss in the past few years

Otherwise, effectiveness outcomes were comparable between the two groups. The researchers said future long-term CV clinical trials conducted for older adults with type 2 diabetes need to assess frailty to better establish the risk-benefit profiles of using a specific medication.

The oral semaglutide offered through MadeMed is a compounded sublingual formulation - it is not the same product, does not use the same proprietary absorption technology, and has not been independently evaluated by the FDA for bioavailability, dosing equivalence, or absorption characteristics relative to the FDA-approved version

Find out if genetic testing is right for you